Tazomeline
Alternative Names: Hexylthio-TZTP; LY 287041; NNC 110309Latest Information Update: 28 Jun 2001
At a glance
- Originator Eli Lilly and Company
- Class Neuroprotectants; Nootropics
- Mechanism of Action Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Jun 2001 No-Development-Reported for Alzheimer's disease in USA (Unknown route)
- 09 Jul 1998 LY 287041 is now called tazomeline
- 22 Jul 1997 Phase-I clinical trials for Alzheimer's disease in USA (Unknown route)